Verastem to Present at 2015 UBS Global Health Care Conference

BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the 2015 UBS Global Healthcare Conference on Tuesday, May 19 at 1:30 p.m. ET at the Sheraton New York Times Square Hotel in New York City.

A live webcast of the presentation will be available on the company's website at http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-calendar. An archived presentation will be available for 90 days.

About Verastem, Inc.

Verastem, Inc. (NASDAQ: VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK and PI3K/mTOR. For more information, please visit www.verastem.com.

Verastem, Inc.
Brian Sullivan, 781-292-4214
[email protected]

Source: Verastem, Inc.

You May Also Be Interested In

• Ivanhoe Electric to Release the 2026 Santa Cruz Copper Project Preliminary Feasibility Study Before U.S. Markets Open on September 23, 2026
• GBank Financial Holdings Inc. Highlights Strategic Updates Included in Investor Presentation
• Cohen & Steers Closed-End Funds Declare Distributions for October, November, and December 2026